Cosmos Pharmaceutical Corp
TSE:3349
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cosmos Pharmaceutical Corp
TSE:3349
|
JP |
|
D
|
DeFi Development Corp
XMUN:F6S0
|
US |
|
Fresh Del Monte Produce Inc
NYSE:FDP
|
US |
|
DSV A/S
F:DS81
|
DK |
|
T
|
Tamarack Valley Energy Ltd
OTC:TNEYF
|
CA |
|
H
|
Hanger Inc
F:HO8
|
US |
|
Landstar System Inc
NASDAQ:LSTR
|
US |
|
Mitsui Fudosan Co Ltd
OTC:MTSFF
|
JP |
|
Ipsen SA
PAR:IPN
|
FR |
|
Great Panther Mining Ltd
OTC:GPLDF
|
CA |
|
Toyota Motor Corp
NYSE:TM
|
JP |
|
Itron Inc
NASDAQ:ITRI
|
US |
|
A
|
Apple Inc
XHAM:APC
|
US |
|
E
|
Eiffage SA
SWB:EF3
|
FR |
|
B
|
Bel Fuse Inc
NASDAQ:BELFB
|
US |
|
Apple Hospitality REIT Inc
NYSE:APLE
|
US |
|
Capitol Federal Financial Inc
NASDAQ:CFFN
|
US |
|
Great Elm Capital Corp
NASDAQ:GECC
|
US |
|
S
|
Supreme PLC
LSE:SUP
|
UK |
|
Alkemy SpA
MIL:ALK
|
IT |
Wall St Price Targets
Price Targets Summary
Cosmos Pharmaceutical Corp
According to Wall Street analysts, the average 1-year price target for Cosmos Pharmaceutical Corp is 9 137.35 JPY with a low forecast of 7 160.9 JPY and a high forecast of 11 550 JPY.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Cosmos Pharmaceutical Corp's stock price target?
Price Target
9 137.35
JPY
According to Wall Street analysts, the average 1-year price target for Cosmos Pharmaceutical Corp is 9 137.35 JPY with a low forecast of 7 160.9 JPY and a high forecast of 11 550 JPY.
What is the Revenue forecast for Cosmos Pharmaceutical Corp?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 3 years is 8%.
What is the Operating Income forecast for Cosmos Pharmaceutical Corp?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Operating Income has been 9%. The projected CAGR for the next 2 years is 10%.
What is the Net Income forecast for Cosmos Pharmaceutical Corp?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Net Income has been 11%. The projected CAGR for the next 3 years is 5%.
